FDA Regulatory-Rulemaking from Real-World Data from Registries
Food and Drug Administration draft guidance outlining recommendations for using real-world data from registries to support regulatory decision-making. Pharmaceutical manufacturers and other life-sciences industry stakeholders should review guidance & submit comments by February 28, 2022
Product Development To Support Labeling Drug Administration Real World Data Assessing Registries Support Regulatory Decision Making Biological Products Guidance
Source: natlawreview.com